DrugPatentWatch Database Preview

Drugs in Development Information for Plinabulin

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Plinabulin?

Plinabulin is an investigational drug.

There have been 9 clinical trials for Plinabulin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1^st 2016.

The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Neutropenia. The leading clinical trial sponsors are BeyondSpring Pharmaceuticals Inc., Jyoti Malhotra, and ICON plc.

There are sixty-three US patents protecting this investigational drug and four hundred and three international patents.

Summary for Plinabulin

US Patents	63
International Patents	403
US Patent Applications	180
WIPO Patent Applications	120
Japanese Patent Applications	50
Clinical Trial Progress	Phase 2 (2016-06-01)
Vendors	46

Recent Clinical Trials for Plinabulin

Title	Sponsor	Phase
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies	M.D. Anderson Cancer Center	Phase 1/Phase 2
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer	Jyoti Malhotra	Phase 1/Phase 2
Plinabulin iv Solution in Prevention of TAC Induced Neutropenia	BeyondSpring Pharmaceuticals Inc.	Phase 2

See all Plinabulin clinical trials

Clinical Trial Summary for Plinabulin

Top disease conditions for Plinabulin

Top clinical trial sponsors for Plinabulin

See all Plinabulin clinical trials

US Patents for Plinabulin

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Plinabulin		Pharmaceutical compositions	Momenta Pharmaceuticals, Inc. (Cambridge, MA)
Plinabulin		Method of treating a brain tumor	BeyondSpring Pharmaceuticals, Inc. (New York, NY)
Plinabulin		Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof	Amgen Fremont Inc. (Fremont, CA)
Plinabulin		Controlled release dosage form	TRIASTEK, INC. (Nanjing, CN)
Plinabulin		Nanoparticle formulations for delivering multiple therapeutic agents	AMRITA VISHWA VIDYAPEETHAM (Kochi, Kerala, unknown)
Plinabulin		Plinabulin compositions	BeyondSpring Pharmaceuticals, Inc. (New York, NY)

International Patents for Plinabulin

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Plinabulin	Australia	AU2014274377	2033-05-28
Plinabulin	Canada	CA2910837	2033-05-28
Plinabulin	European Patent Office	EP3003324	2033-05-28
Plinabulin	Japan	JP2016520613	2033-05-28
Plinabulin	World Intellectual Property Organization (WIPO)	WO2014193818	2033-05-28
Plinabulin	Australia	AU2016229295	2035-03-06